Affymetrix (AFFX) was down 8.3% in late afternoon after pharmaceutical company GlaxoSmithKline cut its stake in the company to 13.4%, or 7,736,254 shares, from 14.5%.

Affymetrix is a maker of microchips and related technologies for genetic analysis.

GlaxoSmithKline was down 1%.